Terumo
Terumo Medical Corporation is the U.S. subsidiary of Terumo Corporation, manufacturing and distributing medical devices such as vascular access products, interventional systems, syringes, and blood collection products for hospitals, clinics, and other healthcare providers. It generates revenue by selling these devices through direct sales and distribution channels across North America.
- Revenue
- $250M - $1B
- Employees
- 1,001 - 5,000
- Founded
- 1972
- Headquarters
- Somerset, United States of America
Terumo customers on Arbolus
Customers who reviewed Terumo
Seniority of Terumo customers
Most people who reviewed Terumo hold C-Suite roles (62%), followed by Director (38%).
- C-Suite 62%
- Director 38%
Customers sample
Employer names and spend open once the report publishes.
What 10 Arbolus experts think of Terumo
NPS scores are highly favorable, with 56% of responses at 9 or 10, and an overall positive skew. Renewal intent is confirmed among all spenders who disclosed renewal data, with 'Not Sure' responses only from operations-focused roles with low spend. All users report being in the more-than-a-year implementation stage except one pilot case. Sentiment is strongly positive and anchored by satisfaction among clinical stakeholders. Positive
Tell us when the Terumo report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
60 Net Promoter Score, from 10 scored reviews- Promoters 6
- Passives 4
- Detractors 0
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 60%Plan to renew, by seniority
- 33% 3 answers
- 100% 2 answers
- 9.3/10 Average score from customers who will renew
- 7/10 Average score from undecided customers
For people who use Terumo
Do you use Terumo at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 10 customers of Terumo have already contributed
Takes a few minutes. Your identity stays anonymous.